Search In this Thesis
   Search In this Thesis  
العنوان
Leptin Gene Polymorphism and Dyslipidemia in Obese Diabetic Patients: Pilot Study/
المؤلف
Younis,Nermin Rabie Abdelwahab
هيئة الاعداد
باحث / نرمين ربيع عبد الوهاب يونس
مشرف / سلوى إبراهيم بكر
مشرف / نرمين تيسير فؤاد
مشرف / دينا علي محمد علي رجب
تاريخ النشر
2017
عدد الصفحات
98.p:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب (متفرقات)
تاريخ الإجازة
1/1/2017
مكان الإجازة
جامعة عين شمس - كلية الطب - Clinical Pathology
الفهرس
Only 14 pages are availabe for public view

from 98

from 98

Abstract

The prevalence of obesity has steadily been rising over the past decades in adults and children, to become a global epidemic and represent a major public health challenge. Obesity is a multifactorial condition influenced by the combined effects of genes, environment and their interactions. Despite intense efforts, the genetic pathways underlying obesity remain elusive.
Many studies have identified the role of genetic variants related to obesity, although the results are still contradictory. This may have occurred due to the diversity of the ethnic groups involved and their respective genetic variability as well as to variations in age, gender, and sample size. Furthermore, there is divergence regarding diets and lifestyles, which modulate the phenotype of body weight.
Leptin is a key hormone in the regulation of body weight. Synthesized and secreted by the adipose tissue, it functions as an afferent satiety signal for the hypothalamus, where it triggers a cascade of neuroendocrine responses that result in the inhibition of orexigenic peptides. These events regulate appetite and metabolism, controlling the body fat mass.
About 60–90% of patients with type 2 diabetes are obese. Insulin resistance is a characteristic feature in abdominal obesity. Both diabetes and obesity have a strong genetic component, and their inheritance is polygenic. Furthermore, they may share a common genetic background, that is, the risk alleles for obesity may also be involved in the increased risk of developing type 2 DM.

Key word:
Low-density lipoprotein, Metabolically healthy obese, Oral glucose tolerance test, Glutamine, Subcutaneous adipose tissue, Total cholesterol